Search Results 301-310 of 17518 for what is vedolizumab
The purpose of this extension study is to monitor the safety and effectiveness of etrolizumab treatment in patients with moderate to severely active Crohn's ...
Crohn's disease — which causes tissues in the digestive tract to become inflamed. Inflammatory bowel disease (IBD) · Irritable bowel syndrome — a group of ...
... vedolizumab at a dose approved for the treatment of UC and failed to respond to or tolerate such treatment; Is naïve to biologic therapy (TNF antagonists or ...
The purpose of this study is to assess if infliximab drug levels in patients who have Ulcerative Colitis predict the risk of needing a colectomy. Additionally, ...
Chronic diarrhea can indicate a serious disorder, such as ulcerative colitis or Crohn's disease, or a less serious condition, such as irritable bowel syndrome.
This surgery removes the large intestine. It's often done to treat ulcerative colitis and other bowel conditions.
Certain diseases that affect the colon, such as ulcerative colitis or Crohn's disease, also may put people at risk of pseudomembranous colitis. C. difficile ...
Ulcerative colitis is an inflammatory bowel disease (IBD) that causes long-lasting inflammation and ulcers (sores) in your digestive tract.
The purpose of this extension study is to evaluate the safety and effectiveness of ozanimod in subjects with moderately to severely active Crohn's Disease.
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC). Print details.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.